The Mumbai-headquartered firm said it will make the active pharmaceutical ingredients (API) - losartan potassium and hydrochlorothiazide – at its facilities in Pithampur, Madhya Pradesh and Roha, Maharashtra.
Unichem also confirmed in a Bombay Stock Exchange (BSE) filing that it will make the finished formulation of the drug – which is a version of Merck & Co’s blood pressure pill - at its manufacturing facility in Ghaziabad, Uttar Pradesh.
The US Food and Drug Administration (FDA) approved Unichem’s version of the drug earlier this week.